Skip to main content
Humedix Co., Ltd. logo

Humedix Co., Ltd. — Investor Relations & Filings

Ticker · 200670 ISIN · KR7200670008 KO Manufacturing
Filings indexed 317 across all filing types
Latest filing 2023-05-25 Director's Dealing
Country KR South Korea
Listing KO 200670

Humedix Co., Ltd. is a healthcare company that develops and manufactures biological and pharmaceutical products focused on human health and beauty. The company specializes in hyaluronic acid-based applications, producing medical devices such as dermal fillers and arthritis treatments. Its portfolio also includes prescription medicines, active pharmaceutical ingredients (APIs), and functional cosmetics. Additionally, Humedix offers Contract Manufacturing Organization (CMO) services within the healthcare sector.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share acquisition (장내매수) by an executive (이지훈) of Humedix. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2023-05-25 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) event (Corporate Day). It specifies the date, location, purpose, and target audience for the meeting. Since it is an announcement of an upcoming event rather than the presentation slides themselves, and it serves as a regulatory notification of corporate activity, it fits the 'Regulatory Filings' (RNS) category as a general announcement of company events.
2023-05-22 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Humedix regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2023-05-17 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Humedix' covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business operations, and management disclosures required for a quarterly filing. According to the provided definitions, this falls under the 'Interim / Quarterly Report' category. Q1 2023
2023-05-11 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Humedix regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure and share count. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2023-05-11 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Humedix regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares issued, the conversion price, and the remaining balance of convertible bonds. This type of filing relates to changes in capital structure due to the conversion of debt into equity, which falls under the 'Share Issue/Capital Change' category.
2023-05-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.